Brief: Voyager Therapeutics Announces Appointment Of Beth Shafer As Chief Business Officer
Aug 7 (Reuters) - Voyager Therapeutics Inc VYGR.O :
* VOYAGER THERAPEUTICS ANNOUNCES APPOINTMENT OF BETH SHAFER
AS
CHIEF BUSINESS OFFICER
Source text for Eikon: ID:nGNX7GKC8N
Further company coverage: VYGR.O
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview